| __timestamp | Arrowhead Pharmaceuticals, Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 12402000000 |
| Thursday, January 1, 2015 | 57410147 | 17449000000 |
| Friday, January 1, 2016 | 41454452 | 17834000000 |
| Sunday, January 1, 2017 | 31690298 | 19551000000 |
| Monday, January 1, 2018 | 52968505 | 18265000000 |
| Tuesday, January 1, 2019 | 81048686 | 15607000000 |
| Wednesday, January 1, 2020 | 128874979 | 15410000000 |
| Friday, January 1, 2021 | 206342000 | 16541000000 |
| Saturday, January 1, 2022 | 297307000 | 17482000000 |
| Sunday, January 1, 2023 | 353188000 | 19381000000 |
| Monday, January 1, 2024 | 505870000 | 22873000000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment.
Dr. Reddy's Laboratories, a global pharmaceutical giant, has consistently allocated substantial resources to R&D, with expenditures peaking at approximately $22.9 billion in 2024. This represents a steady increase of around 85% from 2014, underscoring their dedication to advancing healthcare solutions.
Conversely, Arrowhead Pharmaceuticals, a smaller yet dynamic player, has shown remarkable growth in R&D spending, surging from $23 million in 2014 to over $500 million in 2024. This exponential increase of over 2,000% highlights their aggressive pursuit of cutting-edge therapies.
These trends reflect the diverse strategies companies employ to drive innovation and maintain competitiveness in the pharmaceutical industry.
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Merck & Co., Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
R&D Spending Showdown: Incyte Corporation vs Arrowhead Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
Xenon Pharmaceuticals Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How ACADIA Pharmaceuticals Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Arrowhead Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Geron Corporation
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.